WO1995013396A2 - A method for identifying microorganisms, and aids useful thereof - Google Patents

A method for identifying microorganisms, and aids useful thereof Download PDF

Info

Publication number
WO1995013396A2
WO1995013396A2 PCT/NL1994/000283 NL9400283W WO9513396A2 WO 1995013396 A2 WO1995013396 A2 WO 1995013396A2 NL 9400283 W NL9400283 W NL 9400283W WO 9513396 A2 WO9513396 A2 WO 9513396A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
primers
amplification
dna
electrophoresis
Prior art date
Application number
PCT/NL1994/000283
Other languages
French (fr)
Other versions
WO1995013396A3 (en
Inventor
Adriaan Camille Fluit
Myra Noorely Widjojoatmodjo
Original Assignee
U-Gene Research B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U-Gene Research B.V. filed Critical U-Gene Research B.V.
Publication of WO1995013396A2 publication Critical patent/WO1995013396A2/en
Publication of WO1995013396A3 publication Critical patent/WO1995013396A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Definitions

  • the invention lies in the field of the detection and identification of microorganisms and relates to a method for demonstrating and identifying microorganisms in a sample, and to aids for use in such method.
  • biochemical identification which follows the culturing steps is replaced by an immunological identification with the aid of antibodies, such as in an Enzyme Linked Immuno Sorbent Assay (ELISA) or an Enzyme Immuno Assay (EIA) , or by a genetic identification with the aid of bacterial species-specific DNA probes in a hybridization analysis or bacterial species- specific primers in a polymerase chain reaction (PCR) .
  • ELISA Enzyme Linked Immuno Sorbent Assay
  • EIA Enzyme Immuno Assay
  • PCR polymerase chain reaction
  • the PCR involving an in vitro amplification
  • the PCR can be used to shorten the culturing steps or even render them superfluous.
  • species-specific primers i.e. primers selected within evolutionarily conserved DNA sequences
  • the use of universal primers i.e. primers selected within evolutionarily conserved DNA sequences, gives a positive result but no identification (see K. Chen, H. Neimark, P. Rumore, CR. Steinman. 1989. Broad range DNA probes for detecting and amplif ing eubacterial nucleic acids. FEMS Microbiology Letters 57:19-24).
  • rRNA 16S ribosomal RNA
  • the rRNA itself can be used as a basis for amplification.
  • this requires that first a DNA copy of the rRNA be made.
  • a reverse transcriptase such as avian myeloblastosis virus reverse transcriptase (AMV-RT)
  • AMV-RT avian myeloblastosis virus reverse transcriptase
  • thermostable DNA poly erase which has this activity, for instance Tth-polymerase.
  • hybridization probes or primers used are directed against sequences which are not found in eukaryotes (hence not in humans either) . Accordingly, these primers can be used for demonstrating the presence of unknown bacteria in a sample.
  • a disadvantage of this method is that one must have at one's disposal a large number of (tens of) species-specific probes to be able to identif the different species of bacteria. Accordingly, the system described by Leong has ..rt yet been put into practice.
  • Rapid identification for instance in the case of bacteremia or spotted fever, is often desirable and neither the known culturing method nor the current DNA technology provide any practical solution to this problem.
  • the present invention provides a method for identifying a microorganism present in a sample, comprising subjecting nucleic acid of the microorganism present in the sample to nucleic acid amplification utilizing one or more sets of universal primers which are based on a gene of the microorganism to be identified which comprises both conserved and variable regions, the primers having been selected in conserved regions which enclose a variable region; bringing the product of the nucleic acid amplification into single-stranded form; subjecting the amplification product brought into single- stranded form to an electrophoresis which is capable of separating single-stranded nucleic acids of equal length from each other on the basis of differences in nucleotide sequence; detecting the electrophoresed nucleic acid; and comparing the position of the electrophoresed nucleic acid with those of a set of reference nucleic acids of known microorganisms.
  • the microorganisms can be bacteria, viruses, fungi, actinomycetes or unicellular parasites but preferably consist of bacteria.
  • the sets of universal primers are preferably based on the 16S rRNA gene or the 23S rRNA gene of bacteria.
  • a highly suitable set of primers is based on the regions 1173-1192 and 1370-1389 of the 16S rRNA gene and then preferably consists of the primers ER1/ER2 :
  • ER1 AGG CCC GGG AAC GTA TTC AC [SEQ ID NO:l], and
  • ER2 GAG GAA GGT GGG GAT GAC GT [SEQ ID NO:2] .
  • Another highly suitable set of primers is based on the regions 103-119 and 341-357 of the 16S rRNA gene and then consists preferably of the primers ER3/ER4 :
  • ER3 GGC GGA CGG GTG AGT AA [SEQ ID NO: 3], and
  • ER4 ACT GCT GCC TCC CGT AG [SEQ ID NO:4] .
  • ER5/ER6 and ER7/ER8 are also useful.
  • ER5 GCA ACG CGA AGA ACC TTA CC [SEQ ID NO: 5]
  • ER6 AGC CAT GCA GCA CCT GTC TC [SEQ ID NO: 6] , based on the regions 966-985 and 1041-1060 of the 16S rRNA gene; as well as
  • ER7 GGA ACT GAA ACA TCT AAG TA [SEQ ID NO:7]
  • ER8 CGG TAC TGG TTC ACT ATC GG [SEQ ID NO: 8], based on the regions 188-207 and 444-463 of the 23S rRNA gene.
  • At least two sets of primers be used in the nucleic acid amplification.
  • This plurality of sets of primers can be used simultaneously in a multiplex amplification.
  • a highly suitable multiplex PCR is obtained when the primer sets ER1/ER2 and ER3/ER4 are combined in one PCR incubation. Because the subsequent analysis takes place in one lane of the electrophoresis gel, a larger number of bands are obtained, the advantage being a better discrimination between the different bacterial species .
  • a plurality of sets of primers can also be used in a 'nested' nucleic acid amplification where a first amplification with a first set of primers is followed by a second amplification with a second set of primers, the primers of the second set being based on regions located between those of the first set of primers.
  • a 'nested' nucleic acid amplification leads to an improved detection limit (sensitivity) .
  • the nucleic acid amplification preferably consists of a polymerase chain reaction (PCR) using a DNA polymerase, more particularly a thermostable DNA polymerase, such as Taq- polymerase, Vent-polymerase, Tth-polymerase, or SuperTag- polymerase (SuperTag is a tradename) .
  • PCR polymerase chain reaction
  • a DNA polymerase more particularly a thermostable DNA polymerase, such as Taq- polymerase, Vent-polymerase, Tth-polymerase, or SuperTag- polymerase (SuperTag is a tradename) .
  • the DNA polymerase is subjected to a pretreatment by which contaminating DNA and/or RNA is removed.
  • the target nucleic acid in the PCR consists of DNA, viz. genomic DNA of the microorganism (such as the 16S rRNA gene) or cDNA, synthesized by reverse transcription of RNA of the microorganism (such as cDNA synthesized from - 16S rRNA itself) .
  • the nucleic acid amplification can also be carried out according to a transcription-based amplification system (TAS), such as according to a self-sustained sequence replication (3SR) reaction, a nucleic acid system based amplification (NASBA) or a template mediated amplification (TMA) .
  • TAS transcription-based amplification system
  • NASBA nucleic acid system based amplification
  • TMA template mediated amplification
  • the target nucleic acid can in that case consist of RNA or DNA of the microorganism.
  • Methods according to the transcription-based amplification system comprise a DNA synthesis step and an RNA transcription step.
  • an oligonucleotide primer containing a polymerase binding site (a promoter) is hybridized with a target RNA molecule or a denatured target DNA molecule.
  • a cDNA strand is synthesized by reverse transcription with the aid of reverse transcriptase.
  • denaturation through heating
  • a second oligonucleotide is hybridized with the newly synthesized cDNA.
  • reverse transcriptase or DNA polymerase
  • RNA copies are subsequently generated. Four cycles of this process are sufficient to realize a million-fold amplification.
  • the self-sustained sequence replication (3SR) method is a modification of TAS. The most important difference is that the 3SR method is performed isothermally (37-42°C) and that the RNA target is broken down.
  • RNase H is used to break down the RNA in the RNA-cDNA hybrid molecule (formed by the reverse transcriptase) and thereby to enable a conversion of the cDNA into a double-stranded DNA molecule.
  • a promoter sequence is also provided in the second primer, so that transcription can proceed from two terminal ends of the double-stranded DNA molecule.
  • the RNA formed in this reaction is converted again into a RNA-cDNA hybrid molecule, so that the reaction sustains itself. In 15 minutes an approximately 100,000-fold RNA amplification is realized.
  • labeled primers or labeled nucleotides can be utilized during the nucleic acid amplification.
  • radioactively labeled primers or nucleotides can be utilized, or primers labeled with a fluorochrome, a chemilu inescent substance, biotin or digoxigenin.
  • primers labeled with fluorescein isothiocyanate (FITC) at the 5' end in particular the primers ER1, ER2, ER3 and ER4.
  • FITC fluorescein isothiocyanate
  • the amplified and electrophoresed nucleic acid if it is not labeled, can be detected by staining, for instance by silver staining, ethidium bromide staining or Stains-all staining.
  • electrophoresis of single-stranded nucleic acid use is preferably made of a polyacrylamide gel electrophoresis under non-denaturing conditions.
  • the product of the amplification consists of double- stranded DNA, it is brought into single-stranded form, for instance through heating, before it is subjected to the electrophoresis mentioned. If the product of the amplification consists of single-stranded DNA or RNA, it can be subjected directly to the electrophoresis mentioned.
  • the nucleic acid of the microorganism present in the sample is preferably isolated from the sample before it is subjected to nucleic acid amplification.
  • the sample can for instance consist of a clinical sample, such as urine, feces, sputum or blood, or a food.
  • the invention also provides an aid suitable for use in the new method according to the invention, comprising a set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
  • the invention further provides a set of aids suitable for use in the new method according to the invention, comprising a nucleic acid amplification kit with one or more sets of universal primers which are based on a gene of the microorganism to be identified which comprises both conserved and variable regions, the primers being selected in conserved regions which enclose a variable region; an electrophoresis kit for an electrophores: ' : which is capable of separating single-stranded nucleic acids of equal lengths from each other on the basis of differences in nucleotide sequence; means for detecting labeled or unlabeled electrophoresed nucleic acid; and a " set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
  • the present invention employs PCR (or a different nucleic acid amplification method) using suitably chosen universal primers, combined with an electrophoresis of the amplification product, in which sequence-dependent differences in mobility (“Sequence Dependent Differences in Mobility” [SDDM] ) of single- stranded DNA (ssDNA) or RNA occur.
  • SDDM Sequence Dependent Differences in Mobility
  • PCR-SSCP PCR-single-stranded conformation polymorphism method
  • PCR-SSCP has been designed for demonstrating a single point mutation.
  • the PCR-SSCP looks at a small change in the mobility of the ssDNA with the point mutation with respect to 'wild-type' ssDNA. This technique is used for demonstrating a single point mutation in oncogenes and in hereditary diseases.
  • the DNA sequence which contains a possible point mutation is first amplified by means of the PCR.
  • the amplified product is then denatured to form two single-stranded DNAs and analyzed by means of non-denaturing polyacrylamide gel electrophoresis.
  • the DNA Under non-denaturing conditions the DNA has a secondary structure which is the result of the nucleotide sequence and the composition of the solution in which the DNA is present.
  • a change in the nucleotide composition need not always result in a change in the secondary structure.
  • the mobility of the ssDNA during gel electrophoresis depends on the secondary structure formed. It is not to be predicted how the secondary structure influences the mobility. However, the expected change in mobility is slight because the length of the ssDNA fragment plays a dominant role in determining the mobility.
  • such an electrophoresis step is used for identifying (i.e. determining) bacterial species, not for demonstrating a single point mutation as happens in PCR-SSCP.
  • the principle of the present method (PCR-SDDM) for identifying bacteria is as follows.
  • PCR-SDDM PCR-SDDM
  • a DNA sequence is amplified which encloses a species-specific sequence.
  • the amplified DNA is denatured (brought into single-stranded form) and subjected to non-denaturing gel electrophoresis. It is supposed that the species-specific sequence gives rise to different secondary structures and mobilities in the gel.
  • the identity of the unknown bacterium can be determined.
  • the present method does not look at the presence or absence of a single point mutation by determining a slight change in mobility of a ssDNA molecule as a result of this mutation, but at the mobility of an ssDNA molecule (in principle a random one) relative to a set of markers to subsequently determine the identity of a bacterium on the basis of this mobility.
  • Detection methods For detecting the electrophoresed DNA or RNA, a staining technique can be used, for instance a silver staining or an ethidium bromide staining. In addition to these staining methods, a large number of other stainings for demonstrating DNA or RNA in gels have been described in the literature. A number of these methods are also suitable for demonstrating ssDNA in PCR-SDDM.
  • An alternative staining is with Stains-all [l-ethyl-2- (l-ethylnaphtho[l,2-d]thiazolin-2-ylidene)-2-methylpropenyl] naphtho[l,2-d]thiazolium bromide; Sigma, St. Louis, MO).
  • the ssDNA band pattern can be recorded with autoradiography or a ⁇ -scanner.
  • the autoradiogram can then be read into the computer with a scanner and be analyzed with suitable software. This enables direct assignment of a species name to an ssDNA band pattern.
  • the data of a ⁇ -scanner can generally be inputted directly into the computer for analysis.
  • chemiluminescent labels for instance acridine esters
  • primers for instance acridine esters
  • the chemiluminescence is recorded either with a film or by means of a camera system. In both cases the data can be analyzed with computer equipment.
  • Labeling the primers with a fluorochrome for instance FITC (the fluorochrome has an influence on the mobility of the ssDNA) , has important advantages. Electrophoresis and analysis of the results can then be coupled by using an automatic DNA sequencer.
  • the principle of an automatic DNA sequencer is that DNA molecules labeled with a suitable fluorochrome are electrophoresed through a polyacrylamide gel. At the lower end of the gel, the fluorochrome is irradiated with laser light of a suitable wavelength. The fluorescence intensity is determined and passed on to a computer. The time a DNA molecule needs to pass the laser is here a measure of the mobility.
  • the FITC-labeled primers are particularly suitable for the detection of the SDDM patterns with the aid of an automatic DNA sequencer.
  • thermostable DNA polymerases for instance Vent-polymerase, Tth-polymerase, SuperTag-polymerase.
  • thermostable DNA polymerases it is often possible to prevent contamination of the polymerase preparation with DNA or RNA originat. ⁇ from the bacterial cell used for isolation of the polymerase in such cases, if any, it will be necessary to treat the preparation with the thermostable DNA polymerase with DNase or RNase to remove contaminating DNA or RNA.
  • DNase is then inactivated through a heat treatment.
  • the RNase can be inactivated by the addition of an inhibitor such as RNasine.
  • the differentiation between different bacterial species can be improved by using a second set of primers.
  • a second set of primers In principle, it is possible to use both sets of primers simultaneously (multiplex PCR) , so that two or more DNA fragments are amplified simultaneously.
  • the primer sets should not be located unduly close to each other because that may give rise to amplification products resulting from the combination of primers from one set with primers of the other set.
  • the amplification products should not be unduly short because otherwise double- stranded amplification product obtained with one primer set might, in the gel electrophoresis, overlap single-stranded product obtained with the second primer set. Nor should the amplification products be unduly long because they might then affect the desired secondary structures too much.
  • the detection limit of the system can be improved by performing a so-called "nested PCR" .
  • this set-up also two sets of primers are used.
  • the second set of primers then lies between the positions of the primers in the first set.
  • the first set is used during, for instance, 30 cycles, and a part of the PCR sample is then used for a second amplification of 30 or 35 cycles with the second set of primers.
  • RNA instead of DNA it is also possible to use RNA as target sequence.
  • the advantage of using the rRNA is that up to 10,000 copies per cell can be present.
  • the rRNA is then converted into a cDNA which subsequently serves as starting material for the above-described PCR methods .
  • NASBA nucleic acid system based amplification
  • the principle of 3SR and that of the NASBA are comparable and both are derived from the transcription-based amplification system (TAS) (D.Y. Kwoh, G.R. Davis, K.M. Whitfield, H.L.
  • TAS transcription-based amplification system
  • NASBA Transcription- based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format. Proceedings National Academy of Sciences USA 86:1173-1177) .
  • the principle of the NASBA is as follows.
  • a specific primer PI which has a T7 promoter sequence at the 5 '-end, a double-stranded DNA-RNA hybrid is made of the target RNA molecule using AMV-reverse transcriptase (AMV-RT) .
  • AMV-RT AMV-reverse transcriptase
  • the second specific primer P2 can hybridize (anneal) with the ss-cDNA formed and the DNA-dependent DNA polymerase activity of AMV-RT makes the ss-cDNA double-stranded.
  • the produc is a double- stranded DNA molecule with a T7 promoter.
  • T7 RNA polymerase gives rise to a 100 to 1000-fold increase of the specific RNA.
  • This RNA in turn can be used by AMV-RT for generating new cDNA molecules. This gives rise to a cyclic phase and an enormous increase in the amount of RNA. The entire process takes place at, for instance, 41°C.
  • the RNA product is finally detected and analyzed. With a few small modifications, double- stranded DNA instead of RNA can serve as starting material.
  • RNA is used for SDDM identification.
  • SSCP RNA single-strand conformation polymorphism
  • the invention is also useful for discriminating between genera or strains.
  • the method is in principle also suitable for the identification of fungi (actinomycetes) and unicellular parasites.
  • the universal primers desribed herein cannot be used because eukaryotes lack the species-specific part of the rRNA chosen for the bacteria. Fungi have no insertions in the rRNA sequence compared with human (mammalian) rRNA. On the other hand, species-specific sequences can be indicated which are flanked by conserved sequences, where universal eukaryotic primers can be selected. Contamination of the samples by human rRNA or rRNA DNA, however, leads to additional products in the PCR-SDDM, which may affect the interpretation of the data.
  • Plasmodium the causer of malaria
  • unique insertions in the rRNA have been described, but in such circumstances it is more obvious to look with Plasmodium specific primers.
  • the above-mentioned universal eukaryotic primers will have to be used.
  • viruses are rendered more difficult because of the strong heterogeneity of viruses. They generally do not have any common sequences. Exceptions are enteroviruses, for which universal primers have been described. However, in the case of viruses the present method can be used for (epidemiologically) typefying isolates, for instance for discriminating between different serotypes of adenovirus, human papilloma virus (HPV) and human immunodeficiency virus types 1 and 2 (HIV) . In such cases, species-specific primers will have to be used which enclose strain-specific sequences. Quantitative PCR-SDDM
  • the PCR-SDDM can be adapted for quantitatively determining the amount of DNA or RNA in a sample and hence the number of microorganisms that are present. This may for instance be important in the quality assurance of water or for monitoring anti-microbial therapy. To this end, before the PCR step a known amount of DNA or RNA must be added. However, the PCR product should have a different mobility in the gel than the DNA to be quantified.
  • the amount of DNA or RNA and hence the number of microorganisms present in the sample can be determined.
  • Sample preparation when using loose colonies or pure cultures Gram-negative bacteria were cultured overnight on blood agar plates at 37°C, then scraped off the plates and lysed in deionized water with 5-10% chelex 100 (Biorad, Richmond, CA) by heating at 95°C for 5 minutes.
  • Gram-positive bacteria were lysed in 0.01% sodium dodecyl sulfate (SDS) and 5-10% chelex 100 by heating at 95°C for 5 minutes. After the lysis 0.5% Nonidet P-40 (Sigma, St. Louis, MO) was added to prevent inhibition of the Tag-polymerase by SDS.
  • SDS sodium dodecyl sulfate
  • Blood sample preparation for detecting bacteremia usin ⁇ the PCR
  • the sample preparation consisted of lysis of the blood cells followed by a filter concentration of any bacteria present. With the aid of this method (relatively) large volumes of blood could be lysed. At least 2 ml blood could be worked up by this method.
  • EDTA or citrate blood was diluted 1:1 with 1% Nonidet P40 (NP40; Sigma, St. Louis, MO) and frozen. After defrosting the sample was centrifuged for 5 minutes at 4000 x g and a temperature of +4°C. The pellet was washed once with 0.5% NP40, and then centrifuged for 5 minutes at 4000 x g, followed by washing once with physiological salt and subsequent centrifugation at 4000 x g for 5 minutes.
  • NP40 Nonidet P40
  • the pellet obtained was resuspended in 200 ⁇ l 1 x PCR buffer (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl 2/ 0.01% (weight/volume) gelatin) and incubated with 300 ⁇ g DNase I at 37°C for 15 minutes. Then the suspension was filtered through a 0.22 ⁇ m Durapore membrane filter (GVHP filter) (Millipore, Bedford, MA), and the filter was then washed twice with physiological salt. The filter was transferred to a 0.5 ml Eppendorf tube and any bacteria present were lysed in 50 ⁇ l 5%-10% chelex in deionized water by heating at 95°C for 10 minutes. After a centrifugation of 30 seconds at about 12,000 x g, 20 ⁇ l of the supernatant was used for PCR amplification.
  • 1 PCR buffer 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM
  • PCR was carried out for 35 cycles with primers directed against conserved 16S and 23S rRNA gene sequences (Chen et al. 1989, FEMS Microbiology Letters 57: 19-24, and G. van Camp, S. Chapelle and R. de Wachter. Amplification and sequencing of variable regions in bacterial 23S ribosomal RNA genes with conserved primer sequences. Current Microbiol. 1993, 27: 147- 151). ⁇
  • Primer sets ER1/ER2, ER3/ER4 and ER5/ER6 are directed against 16S rRNA gene sequences and primer set ER7/ER8 is directed against 23S rRNA gene sequences.
  • ER1 5'-AGG CCC GGG AAC GTA TTC AC (nucleotide nos. 1173-1192) and
  • ER2 5 '-GAG GAA GGT GGG GAT GAC GT (complementary to nucleotide nos. 1370-1389);
  • ER3 5'-GGC GGA CGG GTG AGT AA (nucleotide nos. 103-119) and ER4: 5' -ACT GCT GCC TCC CGT AG (complementary to nucleotide nos. 341-357); ER5: 5' -GCA ACG CGA AGA ACC TTA CC (nucleotide nos. 966-985) and
  • ER6 5 ' -AGC CAT GCA GCA CCT GTC TC (complementary to nucleotide nos. 1041-1060);
  • ER7 5' -GGA ACT GAA ACA TCT AAG TA (nucleotide nos. 188-207) and ER8: 5' -CGG TAC TGG TTC ACT ATC GG (complementary to nucleotide nos . 444-463) .
  • the PCR reaction mixture (50 ⁇ l) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl 2 , 0.01%
  • each primer 100 ⁇ M of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 ⁇ M of each dNTP (dATP, dCTP, dGTP, dTTP) ; or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl 2 , 2 mg/ml bovine serum albumin, 16 mM (NH 4 ) 2 S0 4 , 100 ⁇ M of each primer, 0.1 U
  • Amplification of the target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2, 255 bp for primer set ER3/ER4, 95 bp for primer set E5/ER6, and 276 bp for primer set
  • the PCR reaction mixture (50 ⁇ l) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl 2 , 0.01%
  • each primer 100 ⁇ M of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 ⁇ M of each dNTP (dATP, dCTP, dGTP, dTTP); or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl 2 , 2 mg/ml bovine serum albumin, 16 mM (NH 4 ) 2 S0 4 , 100 ⁇ M of each primer, 0.1 U Super-Tag polymerase (HT Biotechnology, Cambridge, UK) and 100 ⁇ M of each dNTP (dATP, dCTP, dGTP, dTTP).
  • Amplification of target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2 and 255 bp for primer set ER3/ER4 (small differences depending on bacterial species are possible) .
  • Electrophoresis was performed at room temperature with
  • the ethidium bromide staining was carried out as follows. The gel was immersed for 5 minutes in a solution of 1 ⁇ g/ml ethidium bromide in 0.6 x TBE buffer followed by excess removal in 0.6 x TBE for 15 min. DNA bands were visualized with UV light. In the silver staining the gels were first fixed in 50% methanol at 37°C for 30 minutes and then washed twice with deionized water. The gels were treated with 0.1% silver nitrate, 0.056% NaOH and 0.375% NH 4 OH at 37°C for 15-30 minutes. Color development occurred through incubation with 0.005% citric acid and 0.019% formaldehyde. The gels were washed with deionized water and the color development was stopped with 50% methanol and 5% acetic acid.
  • the gels were first fixed in 10% acetic acid for 20 minutes and then washed three times with deionized water for 2 minutes.
  • the gels were treated with silver nitrate (1 g/1), 1.5 ml 37% formic acid per liter for 30 minutes.
  • the gel was washed with deionized water for 20 seconds.
  • Color development occurred through 2-5 minute incubation with 30 g/1 sodium carbonate, 1.5 ml 37% formic acid per liter and 2 mg/1 Na 2 S 2 ⁇ 3.5H 2 O.
  • the color development was stopped by treating the gels with 10% acetic acid for 5 min. All incubations were carried out at room temperature.
  • Example 2 use of fluorescein isothiocyanate labeled primers followed by analysis with an automatic DNA sequencer
  • the PCR was performed for 35 cycles with primers directed against conserved 16S rRNA gene sequences.
  • the two primer sets ER1/ER2 and ER3/ER4 were used, the 5 ' -ends of the primers being labeled with fluorescein isothiocyanate (FITC) .
  • FITC fluorescein isothiocyanate
  • the PCR reaction mixture (50 ⁇ l) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl 2 , 0.01%
  • each primer 100 ⁇ M of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 ⁇ M of each dNTP (dATP, dCTP, dGTP, dTTP); or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl 2 , 2 mg/ l bovine serum albumin, 16 mM (NH 4 ) 2 S0 4 , 100 ⁇ M of each primer, 0.1 U
  • Amplification of target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2 and 255 bp for primer set
  • ER3/ER4 small differences depending on bacterial species are possible.
  • the primer combinations ER1/ER2 and ER3/ER4 can be combined in one PCR incubation (multiplex PCR) .
  • the use of 0.5xMDE gel gave a better resolution.
  • the gel thickness used was 0.5 mm.
  • Electrophoresis was carried out at 30°C with 0.6xTBE buffer at 30 W continuous output for 300 minutes for a 20 x 34 cm (1 x b) gel and for 800 minutes for a 30 x 34 cm (1 x b) gel.
  • the electrophoresis was carried out on an ALF DNA sequencer (Pharmacia, Sweden) .
  • ALF DNA sequencer Pharmacia, Sweden
  • other automatic DNA sequencers can be used as well, such as automatic
  • markers were added to each sample. These markers were used to correct the small local differences in electrophoresis conditions which are present in the gel.
  • the markers consisted of a sequence coming from the gene for toxin B of Clostridium difficile .
  • the size of the markers was chosen such that one marker has a mobility that is greater than that of the products obtained with PCR-SDDM and one marker has a mobility smaller than the PCR-SDDM products. (Note: of course, other DNA sequences meeting the above-mentioned conditions can also be used as markers) .
  • markers 150 nucleotides 150 nucleotides, 203 nucleotides and 257 nucleotides.
  • the markers of 150 and 257 nucleotides were used in multiplex PCR-SDDM with primers ER1/ER2 and ER3/ER4.
  • the markers of 150 and 203 nucleotides were used for
  • the markers are obtained with the aid of PCR.
  • primers were used (nucleotide numbers are derived from the toxin B gene sequence published by L.A. Barroso,
  • TOXB321r 5'-CTT TAG CTC TAA TAC TTC TG (complementary to nucleotide nos. 638-657);
  • TOXB428r 5 * -CTA TTT ACA TCT TTC CAT TG (complementary to nucleotide nos. 755-764).
  • 91.50 with 90.11 gives the product of 203 nucleotides
  • 91.50 with TOXB321r the product of 150 nucleotides
  • 91.50 with TOXB428r the product of 257 nucleotides.
  • the following PCR conditions were used. A suspension of toxigenic Clostridium diffcile in water was heated at 95°C for 5 min.
  • Used as marker was 0.2 ⁇ l of the incubation mixture in 5 ⁇ l 95% formamide, 5 mM EDTA and 0.05% dextran blue.
  • Proteus mirabilis Proteus vulgar is 2 32 Pseudomonas aeruginosa 3 33 Pseudomonas fluorescens 1
  • the ssDNA patterns were species-specific, except that the tested Proteus spp. gave the same pattern. The same result was also obtained with Citrobacter freundii and Citrobacter amalonaticus . This was also the case for Escherichia coli / Salmonella enterica / Shigella spp. group. The identical patterns between Escherichia coli and the Shigella spp. were not entirely unexpected because both species are about 99% identical at a genetic level and are considered to be of the same species by some (D.J. Brenner. Introduction to the family Enterobacteriaceae. In: A. Balows, H.G. Truper, M. Dworkin, W. Harder, K.H.
  • primer set ER3/ER4 it is possible to discriminate Proteus mirabilis from Proteus vulgaris and Citrobacter freundii from Citrobacter amalonaticus .
  • Escherichia coli / Salmonella enterica / Shigella spp. group a distinction could be made between Escherichia coli , Salmonella enterica and the Shigella .
  • Shigella spp. no distinction could be made.
  • the primer sets ER1/ER2 and ER3/ER4 can be combined in a multiplex PCR, so that with a single PCR-SDDM analysis the results of the two primer sets can be combined. This does not lead to any loss of discriminative ability.
  • SSDM-PCR with FITC-labeled .1/ER2 primers followed by analysis on an automatic DNA sequencer was applied to 57 bacterial strains selected from 14 species and 7 genera. This resulted in 12 different ssDNA band patterns as summarized in Table 3.
  • Table 3 PCR-SDDM patterns with FITC labeled primers ER1-ER2 and analysis on an automatic sequencer
  • Proteus mirabilis Proteus vulgaris 1
  • the ssDNA band patterns were species-specific, except that the tested Proteus spp. gave the same pattern. This was also the case for Escherichia coli / Salmonella enterica . (These results correspond with the results obtained with the method described in Example 1. )
  • SSDM-PCR with the FITC-labeled ER1/ER2 and ER3/ER4 primer sets followed by analysis on an automatic DNA sequencer was applied to 41 bacterial strains selected from 10 species and 3 genera. This resulted in 10 different ssDNA patterns as summarized in Table 4.
  • Table 4 Multiplex PCR-SDDM patterns with FITC labeled primers ER1-ER2, ER3-ER4 and analysis on an automatic sequencer.
  • the ssDNA band patterns with the FITC-labeled primer sets ER1/ER2 and ER3/ER4 are found to be species-specific for the tested bacterial species.
  • SEQ ID NO:l LENGTH 20 nucleotides TYPE: nucleotides STRANDEDNESS: single AGGCCCGGGA ACGTATTCAC 20
  • LENGTH 20 nucleotides TYPE: nucleotides STRANDEDNESS: single GAGGAAGGTG GGGATGACGT 20
  • LENGTH 17 nucleotides TYPE: nucleotides STRANDEDNESS: single GGCGGACGGG TGAGTAA 17
  • LENGTH 20 nucleotides TYPE: nucleotides STRANDEDNESS: single AGCCATGCAG CACCTGTCTC 20

Abstract

Identification of a microorganism, in particular a bacterium, present in a sample. Nucleic acid (DNA or RNA) of the microorganism present in the sample is subjected to PCR or a different nucleic acid amplification method, utilizing one or more sets of universal primers based on a gene of the microorganism to be identified which comprises both conserved and variable regions, in particular the 16S rRNA gene, the primers being chosen in conserved areas which enclose a variable region. The product of the amplification is brought into single-stranded form, if necessary, and subjected to electrophoresis by which single-stranted nucleic acids of equal lengths can be separated from each other on the basis of differences in nucleotide sequence. The electrophoresed nucleic acid is detected and its position compared with those of a set of reference nucleic acids of known microorganisms. Set of suitable aids for practicing the method.

Description

Title: A method for identifying microorganisms, and aids useful therefor
FIELD UF THE INVENTION
The invention lies in the field of the detection and identification of microorganisms and relates to a method for demonstrating and identifying microorganisms in a sample, and to aids for use in such method.
PRIOR ART
The classic method for demonstrating and identifying microorganisms, in particular in clinical samples, such as urine, feces, sputum and blood, as well as in foods, takes place through culture in enrichment and selective media, followed by biochemical identification.
Sometimes the biochemical identification which follows the culturing steps is replaced by an immunological identification with the aid of antibodies, such as in an Enzyme Linked Immuno Sorbent Assay (ELISA) or an Enzyme Immuno Assay (EIA) , or by a genetic identification with the aid of bacterial species-specific DNA probes in a hybridization analysis or bacterial species- specific primers in a polymerase chain reaction (PCR) . A major disadvantage of the culturing steps which are necessary before the bacteria can be identified is their time-consuming character. Some bacteria, such as Mycobacterium tuberculosis, require a few weeks' culture.
In principle, the PCR, involving an in vitro amplification, can be used to shorten the culturing steps or even render them superfluous. However, this requires that if species-specific primers are used, the bacterial species to be looked for in the sample be known beforehand because otherwise the species-specific primers will give a negative result. By contrast, the use of universal primers, i.e. primers selected within evolutionarily conserved DNA sequences, gives a positive result but no identification (see K. Chen, H. Neimark, P. Rumore, CR. Steinman. 1989. Broad range DNA probes for detecting and amplif ing eubacterial nucleic acids. FEMS Microbiology Letters 57:19-24). Chen et al used DNA hybridization probes which are homologous to conserved parts of bacterial 16S ribosomal RNA (rRNA) sequences. The use of these 16S rRNA gene sequences has a number of advantages. The 16S rRNA gene is found in all bacteria. The gene consists of conserved parts, which are interrupted by species-specific sequences. Generally, several copies of the gene are present in the bacterial cell. As a result, a better/higher sensitivity can be achieved in proportion to non-ribosomal sequences.
Alternatively, the rRNA itself can be used as a basis for amplification. However, this requires that first a DNA copy of the rRNA be made. This can be done with the aid of a reverse transcriptase, such as avian myeloblastosis virus reverse transcriptase (AMV-RT) , or a thermostable DNA poly erase which has this activity, for instance Tth-polymerase. This leads to a further improvement of the sensitivity, because up to 10,000 copies of the rRNA may be present in the bacterial cell.
The hybridization probes or primers used are directed against sequences which are not found in eukaryotes (hence not in humans either) . Accordingly, these primers can be used for demonstrating the presence of unknown bacteria in a sample.
For a directed treatment of patients with e.g. antibiotics, however, it is necessary to know the identity of the bacteria. To identify the bacteria, either the nucleotide sequence will have to be determined or the amplified product of the PCR will have to be hybridized with a large number of species-specific DNA probes. The first-mentioned method (determination of the nucleotide sequence) is time-consuming and costly.
The method utilizing specific probes which hybridize with the species-specific parts of the amplified rRNA sequence has been described for a (theoretical) PCR-based assay for the determination of bacteremia by Roche Molecular Systems (D.U. Leong. 1992. Design of a PCR assay for the rapid detection of bacteremia. Infection in Medicine 7:43-48).
A disadvantage of this method is that one must have at one's disposal a large number of (tens of) species-specific probes to be able to identif the different species of bacteria. Accordingly, the system described by Leong has ..rt yet been put into practice.
Rapid identification, for instance in the case of bacteremia or spotted fever, is often desirable and neither the known culturing method nor the current DNA technology provide any practical solution to this problem.
BRIEF SUMMARY OF THE INVENTION The present invention provides a method for identifying a microorganism present in a sample, comprising subjecting nucleic acid of the microorganism present in the sample to nucleic acid amplification utilizing one or more sets of universal primers which are based on a gene of the microorganism to be identified which comprises both conserved and variable regions, the primers having been selected in conserved regions which enclose a variable region; bringing the product of the nucleic acid amplification into single-stranded form; subjecting the amplification product brought into single- stranded form to an electrophoresis which is capable of separating single-stranded nucleic acids of equal length from each other on the basis of differences in nucleotide sequence; detecting the electrophoresed nucleic acid; and comparing the position of the electrophoresed nucleic acid with those of a set of reference nucleic acids of known microorganisms.
The microorganisms can be bacteria, viruses, fungi, actinomycetes or unicellular parasites but preferably consist of bacteria. In the case of the identification of bacteria, the sets of universal primers are preferably based on the 16S rRNA gene or the 23S rRNA gene of bacteria. A highly suitable set of primers is based on the regions 1173-1192 and 1370-1389 of the 16S rRNA gene and then preferably consists of the primers ER1/ER2 :
ER1: AGG CCC GGG AAC GTA TTC AC [SEQ ID NO:l], and
ER2: GAG GAA GGT GGG GAT GAC GT [SEQ ID NO:2] .
Another highly suitable set of primers is based on the regions 103-119 and 341-357 of the 16S rRNA gene and then consists preferably of the primers ER3/ER4 :
ER3: GGC GGA CGG GTG AGT AA [SEQ ID NO: 3], and
ER4: ACT GCT GCC TCC CGT AG [SEQ ID NO:4] .
Also useful are the following primer combinations ER5/ER6 and ER7/ER8: ER5: GCA ACG CGA AGA ACC TTA CC [SEQ ID NO: 5], and
ER6: AGC CAT GCA GCA CCT GTC TC [SEQ ID NO: 6] , based on the regions 966-985 and 1041-1060 of the 16S rRNA gene; as well as
ER7: GGA ACT GAA ACA TCT AAG TA [SEQ ID NO:7], and ER8: CGG TAC TGG TTC ACT ATC GG [SEQ ID NO: 8], based on the regions 188-207 and 444-463 of the 23S rRNA gene.
It is preferred, with a view to optimum specificity and differentiation between different species of bacteria, that at least two sets of primers be used in the nucleic acid amplification. This plurality of sets of primers can be used simultaneously in a multiplex amplification. A highly suitable multiplex PCR is obtained when the primer sets ER1/ER2 and ER3/ER4 are combined in one PCR incubation. Because the subsequent analysis takes place in one lane of the electrophoresis gel, a larger number of bands are obtained, the advantage being a better discrimination between the different bacterial species .
A plurality of sets of primers can also be used in a 'nested' nucleic acid amplification where a first amplification with a first set of primers is followed by a second amplification with a second set of primers, the primers of the second set being based on regions located between those of the first set of primers. Such a 'nested' nucleic acid amplification leads to an improved detection limit (sensitivity) . The nucleic acid amplification preferably consists of a polymerase chain reaction (PCR) using a DNA polymerase, more particularly a thermostable DNA polymerase, such as Taq- polymerase, Vent-polymerase, Tth-polymerase, or SuperTag- polymerase (SuperTag is a tradename) . Preferably, the DNA polymerase is subjected to a pretreatment by which contaminating DNA and/or RNA is removed.
The target nucleic acid in the PCR consists of DNA, viz. genomic DNA of the microorganism (such as the 16S rRNA gene) or cDNA, synthesized by reverse transcription of RNA of the microorganism (such as cDNA synthesized from - 16S rRNA itself) .
However, the nucleic acid amplification can also be carried out according to a transcription-based amplification system (TAS), such as according to a self-sustained sequence replication (3SR) reaction, a nucleic acid system based amplification (NASBA) or a template mediated amplification (TMA) . The target nucleic acid can in that case consist of RNA or DNA of the microorganism.
Methods according to the transcription-based amplification system (TAS) comprise a DNA synthesis step and an RNA transcription step. In the method an oligonucleotide primer containing a polymerase binding site (a promoter) is hybridized with a target RNA molecule or a denatured target DNA molecule. After the hybridization of the primer on the target molecule, a cDNA strand is synthesized by reverse transcription with the aid of reverse transcriptase. After denaturation (through heating) a second oligonucleotide is hybridized with the newly synthesized cDNA. By adding reverse transcriptase (or DNA polymerase) again, a double-stranded DNA molecule is synthesized. By adding an RNA polymerase, RNA copies are subsequently generated. Four cycles of this process are sufficient to realize a million-fold amplification.
The self-sustained sequence replication (3SR) method is a modification of TAS. The most important difference is that the 3SR method is performed isothermally (37-42°C) and that the RNA target is broken down. RNase H is used to break down the RNA in the RNA-cDNA hybrid molecule (formed by the reverse transcriptase) and thereby to enable a conversion of the cDNA into a double-stranded DNA molecule. As a particular aspect, here a promoter sequence is also provided in the second primer, so that transcription can proceed from two terminal ends of the double-stranded DNA molecule. The RNA formed in this reaction is converted again into a RNA-cDNA hybrid molecule, so that the reaction sustains itself. In 15 minutes an approximately 100,000-fold RNA amplification is realized.
For the purpose of detecting the amplified and electrophoresed nucleic acid, labeled primers or labeled nucleotides can be utilized during the nucleic acid amplification. For instance, radioactively labeled primers or nucleotides can be utilized, or primers labeled with a fluorochrome, a chemilu inescent substance, biotin or digoxigenin. Highly suitable are primers labeled with fluorescein isothiocyanate (FITC) at the 5' end, in particular the primers ER1, ER2, ER3 and ER4. The amplified and electrophoresed nucleic acid, if it is not labeled, can be detected by staining, for instance by silver staining, ethidium bromide staining or Stains-all staining.
For the electrophoresis of single-stranded nucleic acid, use is preferably made of a polyacrylamide gel electrophoresis under non-denaturing conditions.
If the product of the amplification consists of double- stranded DNA, it is brought into single-stranded form, for instance through heating, before it is subjected to the electrophoresis mentioned. If the product of the amplification consists of single-stranded DNA or RNA, it can be subjected directly to the electrophoresis mentioned.
The nucleic acid of the microorganism present in the sample is preferably isolated from the sample before it is subjected to nucleic acid amplification. The sample can for instance consist of a clinical sample, such as urine, feces, sputum or blood, or a food.
The invention also provides an aid suitable for use in the new method according to the invention, comprising a set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
The invention further provides a set of aids suitable for use in the new method according to the invention, comprising a nucleic acid amplification kit with one or more sets of universal primers which are based on a gene of the microorganism to be identified which comprises both conserved and variable regions, the primers being selected in conserved regions which enclose a variable region; an electrophoresis kit for an electrophores:' : which is capable of separating single-stranded nucleic acids of equal lengths from each other on the basis of differences in nucleotide sequence; means for detecting labeled or unlabeled electrophoresed nucleic acid; and a" set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
DETAILED DESCRIPTION OF THE INVENTION
The present invention employs PCR (or a different nucleic acid amplification method) using suitably chosen universal primers, combined with an electrophoresis of the amplification product, in which sequence-dependent differences in mobility ("Sequence Dependent Differences in Mobility" [SDDM] ) of single- stranded DNA (ssDNA) or RNA occur. Incidentally, a similar method, the PCR-single-stranded conformation polymorphism method [PCR-SSCP] has recently been described as a possible method for demonstrating point-mutations (M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi, T. Sekiya. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proceedings National Academy or Sciences USA 86:2766-2770).
PCR-SSCP has been designed for demonstrating a single point mutation. The PCR-SSCP looks at a small change in the mobility of the ssDNA with the point mutation with respect to 'wild-type' ssDNA. This technique is used for demonstrating a single point mutation in oncogenes and in hereditary diseases.
The DNA sequence which contains a possible point mutation is first amplified by means of the PCR. The amplified product is then denatured to form two single-stranded DNAs and analyzed by means of non-denaturing polyacrylamide gel electrophoresis.
Under non-denaturing conditions the DNA has a secondary structure which is the result of the nucleotide sequence and the composition of the solution in which the DNA is present. However, a change in the nucleotide composition need not always result in a change in the secondary structure. The mobility of the ssDNA during gel electrophoresis depends on the secondary structure formed. It is not to be predicted how the secondary structure influences the mobility. However, the expected change in mobility is slight because the length of the ssDNA fragment plays a dominant role in determining the mobility.
In a number of cases, therefore, it is impossible to find a difference in mobility despite the presence of a point mutation (K. Hayashi. 1992. PCR-SSCP: A method for detection of mutations. Genetic Analysis Techniques and Applications 9:73-79).
According to the invention, such an electrophoresis step is used for identifying (i.e. determining) bacterial species, not for demonstrating a single point mutation as happens in PCR-SSCP. The principle of the present method (PCR-SDDM) for identifying bacteria is as follows. By means of universal primers selected in conserved regions of the 16S rRNA gene, a DNA sequence is amplified which encloses a species-specific sequence. The amplified DNA is denatured (brought into single-stranded form) and subjected to non-denaturing gel electrophoresis. It is supposed that the species-specific sequence gives rise to different secondary structures and mobilities in the gel. By determining the mobility of a particular ssSNA relative to one or more reference DNA molecules or markers and relating it to a data base with the mobility of ssDNAs coming from known bacterial species, the identity of the unknown bacterium can be determined. In contrast with the (classic) PCR-SSCP, the present method does not look at the presence or absence of a single point mutation by determining a slight change in mobility of a ssDNA molecule as a result of this mutation, but at the mobility of an ssDNA molecule (in principle a random one) relative to a set of markers to subsequently determine the identity of a bacterium on the basis of this mobility.
Detection methods For detecting the electrophoresed DNA or RNA, a staining technique can be used, for instance a silver staining or an ethidium bromide staining. In addition to these staining methods, a large number of other stainings for demonstrating DNA or RNA in gels have been described in the literature. A number of these methods are also suitable for demonstrating ssDNA in PCR-SDDM. An alternative staining is with Stains-all [l-ethyl-2- (l-ethylnaphtho[l,2-d]thiazolin-2-ylidene)-2-methylpropenyl] naphtho[l,2-d]thiazolium bromide; Sigma, St. Louis, MO).
Direct labeling of the PCR product is possible through the use of radioactivity, fluorochromes, chemiluminescence labels, biotin and digoxigenin systems.
If the PCR reaction is performed in the presence of a suitable radioactive label such as 35S, 32P, 33P deoxynucleotide triphosphates (dNTP) or 32P, 33P labelled primers, the ssDNA band pattern can be recorded with autoradiography or a β-scanner. The autoradiogram can then be read into the computer with a scanner and be analyzed with suitable software. This enables direct assignment of a species name to an ssDNA band pattern. The data of a β-scanner can generally be inputted directly into the computer for analysis.
The use of chemiluminescent labels, for instance acridine esters, is possible only in combination with primers (so the primers are labeled, for the presence of the label has an influence on the mobility) . The chemiluminescence is recorded either with a film or by means of a camera system. In both cases the data can be analyzed with computer equipment.
Labeling the primers with a fluorochrome, for instance FITC (the fluorochrome has an influence on the mobility of the ssDNA) , has important advantages. Electrophoresis and analysis of the results can then be coupled by using an automatic DNA sequencer. The principle of an automatic DNA sequencer is that DNA molecules labeled with a suitable fluorochrome are electrophoresed through a polyacrylamide gel. At the lower end of the gel, the fluorochrome is irradiated with laser light of a suitable wavelength. The fluorescence intensity is determined and passed on to a computer. The time a DNA molecule needs to pass the laser is here a measure of the mobility.
The use of biotin and digoxigenin systems is possible but less practical because after the gel electrophoresis the DNA must be blotted to a nitrocellulose or nylon membrane. After blotting, the position of the DNA fragments is visualized by incubating the blot with a conjugate or an enzyme and either avidin or an anti- digoxigenin antibody, followed by the conversion of a substrate of the enzyme used in the conjugate. The primers ER1, ER2, ER3 and ER4 also give excellent results when they are labeled with FITC at the 5' -end. Although the bands then display a different mobility, the resolution remains excellent or is even better. With the FITC-labeled primer combination ER1/ER2 it has been found possible to reproducibly distinguish Enterobacter aerogenes and Enterobacter cloacae, whereas this sometimes gives rise to problems in the detection through silver staining. The same applies to Listeria monocytogenes and Listeria ivanovii .
The FITC-labeled primers are particularly suitable for the detection of the SDDM patterns with the aid of an automatic DNA sequencer.
Alternatives during and before the PCR
PCR amplification can be performed not only with Taq- polymerase but also with other thermostable DNA polymerases, for instance Vent-polymerase, Tth-polymerase, SuperTag-polymerase. By using other preparations with thermostable DNA polymerases it is often possible to prevent contamination of the polymerase preparation with DNA or RNA originat.π from the bacterial cell used for isolation of the polymerase in such cases, if any, it will be necessary to treat the preparation with the thermostable DNA polymerase with DNase or RNase to remove contaminating DNA or RNA. DNase is then inactivated through a heat treatment. The RNase can be inactivated by the addition of an inhibitor such as RNasine.
The differentiation between different bacterial species (specificity) can be improved by using a second set of primers. In principle, it is possible to use both sets of primers simultaneously (multiplex PCR) , so that two or more DNA fragments are amplified simultaneously. The primer sets should not be located unduly close to each other because that may give rise to amplification products resulting from the combination of primers from one set with primers of the other set. The amplification products should not be unduly short because otherwise double- stranded amplification product obtained with one primer set might, in the gel electrophoresis, overlap single-stranded product obtained with the second primer set. Nor should the amplification products be unduly long because they might then affect the desired secondary structures too much. The detection limit of the system (sensitivity) can be improved by performing a so-called "nested PCR" . In this set-up also two sets of primers are used. The second set of primers then lies between the positions of the primers in the first set. The first set is used during, for instance, 30 cycles, and a part of the PCR sample is then used for a second amplification of 30 or 35 cycles with the second set of primers.
Instead of DNA it is also possible to use RNA as target sequence. The advantage of using the rRNA is that up to 10,000 copies per cell can be present. With the aid of reverse transcriptase, the rRNA is then converted into a cDNA which subsequently serves as starting material for the above-described PCR methods .
An alternative method, however, is the 3SR method (T.R. Gingeras, K.M. Whitfield, D.Y. Kwoh. 1990. Unique features of the self-sustained sequence replication (3SR) reaction in the in vitro amplification of nucleic acids. Ann. Biol. Clin. 48: 498- 501; J.C. Guatelli, K.M. Whitfield, D.Y. Kwoh, K.J. Barringer, D.D. Richman, T.R. Gingeras. 1990. Isothermal, in vitro amplification of nucleic acids by a multi-enzyme reaction modeled after retroviral replication. Proceedings National Academy of Sciences USA 87:1874-1878) and the "nucleic acid system based amplification" (NASBA) (T. Kievits, B. van Gemen, D. van Strijp, R. Schukking, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, P. Lens . NASBA™ isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis or HIV-1 infection. 1991. Journal or Virological Methods 35:273-286).
The principle of 3SR and that of the NASBA are comparable and both are derived from the transcription-based amplification system (TAS) (D.Y. Kwoh, G.R. Davis, K.M. Whitfield, H.L.
Chapelle, L.J. Di Michele, T.R. Gingeras. 1989. Transcription- based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format. Proceedings National Academy of Sciences USA 86:1173-1177) . In summary, the principle of the NASBA is as follows. By means of a specific primer PI, which has a T7 promoter sequence at the 5 '-end, a double-stranded DNA-RNA hybrid is made of the target RNA molecule using AMV-reverse transcriptase (AMV-RT) . RNase H then breaks down the RNA strand of this hybrid. The second specific primer P2 can hybridize (anneal) with the ss-cDNA formed and the DNA-dependent DNA polymerase activity of AMV-RT makes the ss-cDNA double-stranded. The produc is a double- stranded DNA molecule with a T7 promoter. The use of T7 RNA polymerase gives rise to a 100 to 1000-fold increase of the specific RNA. This RNA in turn can be used by AMV-RT for generating new cDNA molecules. This gives rise to a cyclic phase and an enormous increase in the amount of RNA. The entire process takes place at, for instance, 41°C. The RNA product is finally detected and analyzed. With a few small modifications, double- stranded DNA instead of RNA can serve as starting material.
A possible additional advantage of the NASBA system is that the RNA is used for SDDM identification. For SSCP it has been described that the use of RNA leads to greater differences in mobility (G. Sarkar, H.-S. Yoon, S.S. Somer. 1992. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP) : comparison with DNA-SSCP. Nucleic Acids research 20:871-878).
Detection of other microorganisms
Although the most important application of the invention will consist in identifying and discriminating between bacterial species, the invention is also useful for discriminating between genera or strains.
In addition to being suitable for the identification of bacteria, the method is in principle also suitable for the identification of fungi (actinomycetes) and unicellular parasites. The universal primers desribed herein, however, cannot be used because eukaryotes lack the species-specific part of the rRNA chosen for the bacteria. Fungi have no insertions in the rRNA sequence compared with human (mammalian) rRNA. On the other hand, species-specific sequences can be indicated which are flanked by conserved sequences, where universal eukaryotic primers can be selected. Contamination of the samples by human rRNA or rRNA DNA, however, leads to additional products in the PCR-SDDM, which may affect the interpretation of the data. For some parasites, such as Plasmodium (the causer of malaria), unique insertions in the rRNA have been described, but in such circumstances it is more obvious to look with Plasmodium specific primers. Here too, therefore, the above-mentioned universal eukaryotic primers will have to be used.
The use of the present method with viruses is rendered more difficult because of the strong heterogeneity of viruses. They generally do not have any common sequences. Exceptions are enteroviruses, for which universal primers have been described. However, in the case of viruses the present method can be used for (epidemiologically) typefying isolates, for instance for discriminating between different serotypes of adenovirus, human papilloma virus (HPV) and human immunodeficiency virus types 1 and 2 (HIV) . In such cases, species-specific primers will have to be used which enclose strain-specific sequences. Quantitative PCR-SDDM
The PCR-SDDM can be adapted for quantitatively determining the amount of DNA or RNA in a sample and hence the number of microorganisms that are present. This may for instance be important in the quality assurance of water or for monitoring anti-microbial therapy. To this end, before the PCR step a known amount of DNA or RNA must be added. However, the PCR product should have a different mobility in the gel than the DNA to be quantified. By measuring the obtained signal (radioactivity: measuring α, β or γ-radiation or densitometry on the autoradiogram; fluorochrome: fluorescence intensity; silver staining and ethidium bromide: densitometry) and relating it to the signal obtained with known amounts of DNA or RNA which are used for the PCR, the amount of DNA or RNA and hence the number of microorganisms present in the sample can be determined.
Example 1
Sample preparation when using loose colonies or pure cultures Gram-negative bacteria were cultured overnight on blood agar plates at 37°C, then scraped off the plates and lysed in deionized water with 5-10% chelex 100 (Biorad, Richmond, CA) by heating at 95°C for 5 minutes.
Gram-positive bacteria were lysed in 0.01% sodium dodecyl sulfate (SDS) and 5-10% chelex 100 by heating at 95°C for 5 minutes. After the lysis 0.5% Nonidet P-40 (Sigma, St. Louis, MO) was added to prevent inhibition of the Tag-polymerase by SDS.
Blood sample preparation for detecting bacteremia usinσ the PCR The sample preparation consisted of lysis of the blood cells followed by a filter concentration of any bacteria present. With the aid of this method (relatively) large volumes of blood could be lysed. At least 2 ml blood could be worked up by this method.
EDTA or citrate blood was diluted 1:1 with 1% Nonidet P40 (NP40; Sigma, St. Louis, MO) and frozen. After defrosting the sample was centrifuged for 5 minutes at 4000 x g and a temperature of +4°C. The pellet was washed once with 0.5% NP40, and then centrifuged for 5 minutes at 4000 x g, followed by washing once with physiological salt and subsequent centrifugation at 4000 x g for 5 minutes. The pellet obtained was resuspended in 200 μl 1 x PCR buffer (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2/ 0.01% (weight/volume) gelatin) and incubated with 300 μg DNase I at 37°C for 15 minutes. Then the suspension was filtered through a 0.22 μm Durapore membrane filter (GVHP filter) (Millipore, Bedford, MA), and the filter was then washed twice with physiological salt. The filter was transferred to a 0.5 ml Eppendorf tube and any bacteria present were lysed in 50 μl 5%-10% chelex in deionized water by heating at 95°C for 10 minutes. After a centrifugation of 30 seconds at about 12,000 x g, 20 μl of the supernatant was used for PCR amplification.
E£R
The PCR was carried out for 35 cycles with primers directed against conserved 16S and 23S rRNA gene sequences (Chen et al. 1989, FEMS Microbiology Letters 57: 19-24, and G. van Camp, S. Chapelle and R. de Wachter. Amplification and sequencing of variable regions in bacterial 23S ribosomal RNA genes with conserved primer sequences. Current Microbiol. 1993, 27: 147- 151).
Four primer sets were used. Primer sets ER1/ER2, ER3/ER4 and ER5/ER6 are directed against 16S rRNA gene sequences and primer set ER7/ER8 is directed against 23S rRNA gene sequences. ER1: 5'-AGG CCC GGG AAC GTA TTC AC (nucleotide nos. 1173-1192) and
ER2: 5 '-GAG GAA GGT GGG GAT GAC GT (complementary to nucleotide nos. 1370-1389);
ER3: 5'-GGC GGA CGG GTG AGT AA (nucleotide nos. 103-119) and ER4: 5' -ACT GCT GCC TCC CGT AG (complementary to nucleotide nos. 341-357); ER5: 5' -GCA ACG CGA AGA ACC TTA CC (nucleotide nos. 966-985) and
ER6 : 5 ' -AGC CAT GCA GCA CCT GTC TC (complementary to nucleotide nos. 1041-1060);
ER7: 5' -GGA ACT GAA ACA TCT AAG TA (nucleotide nos. 188-207) and ER8: 5' -CGG TAC TGG TTC ACT ATC GG (complementary to nucleotide nos . 444-463) .
Each cycle consisted of 1 minute at 94°C, 1 minute at 55°C,
10 seconds at 72°C. The PCR reaction mixture (50 μl) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2, 0.01%
(weight/volume) gelatin, 100 μM of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP) ; or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl2, 2 mg/ml bovine serum albumin, 16 mM (NH4)2S04, 100 μM of each primer, 0.1 U
Super-Tag polymerase (HT Biotechnology, Cambridge, UK) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP).
Amplification of the target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2, 255 bp for primer set ER3/ER4, 95 bp for primer set E5/ER6, and 276 bp for primer set
ER7/ER8 (small differences depending on bacterial species are possible) .
Multiplex PCR The PCR was carried out for 35 cycles with primers directed against conserved 16S rRNA gene sequences with primer sets
ER1/ER2 and ER3/ER4.
Each cycle consisted of 1 minute at 94°C, 1 minute at 55°C,
10 seconds at 72°C. The PCR reaction mixture (50 μl) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2, 0.01%
(weight/volume) gelatin, 100 μM of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP); or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl2, 2 mg/ml bovine serum albumin, 16 mM (NH4)2S04, 100 μM of each primer, 0.1 U Super-Tag polymerase (HT Biotechnology, Cambridge, UK) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP). Amplification of target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2 and 255 bp for primer set ER3/ER4 (small differences depending on bacterial species are possible) .
Analysis by means of gel electrophoresis
After amplification 5-10 μl of the PCR mixture was added to 5 μl sequencing sample buffer (95% formamide, 5 mM EDTA, 0.05% bromphenol blue and 0.05% xylene cyanol FF) and heated at 95°C for 5 minutes. Then the denatured DNA was directly placed on ice and applied to a gel for analysis after 10 minutes.
Analysis was performed with three different types of polyacrylamide gels . In all cases 10% glycerol was added to improve resolution. The gel types used are:
- 6% bisacrylamide/acrylamide (1:29), 0.05% ammonium persulfate and 0.005% TEMED in 54 mM Tris, 54 mM borate, 1.2 mM EDTA
(0.6xTBE pH 8.3) .
- 6% hydrolink longranger gel (JT Baker, Deventer, Netherlands), 0.05% ammonium persulfate and 0.005% TEMED in 54 mM Tris, 54 mM borate, 1.2 mM EDTA (O.δxTBE pH 8.3). - 0,5 x MDE (Mutation Detection Enhancement) gel (JT Baker),
0.05% ammonium persulfate and 0.005% TEMED in 54 mM Tris, 54 mM borate, 1.2 mM EDTA (0.6xTBE pH 8.3).
The best results were obtained when using 0.5 x MDE gel,
0.6 x TBE and 10% glycerol. When using polyacrylamide gels and longranger gels, a better resolution was obtained with spacers of 0.4 mm than with spacers of 0.75 mm.
Electrophoresis was performed at room temperature with
0.6 x TBE buffer at 1.5 W continuous output for 1.5-2 hours for a 6 x 8 cm gel and at 5 W continuous output for 3-4 hours for a 20 x 20 cm gel. For a 20 x 20 cm gel, also a period of 15 hours at 2W was used, so that the gel electrophoresis could take place overnight. The separation under these conditions was excellent. After the electrophoresis the position (a measure for the mobility) of the ssDNA in the gel was determined with ethidium bromide staining or silver staining.
The ethidium bromide staining was carried out as follows. The gel was immersed for 5 minutes in a solution of 1 μg/ml ethidium bromide in 0.6 x TBE buffer followed by excess removal in 0.6 x TBE for 15 min. DNA bands were visualized with UV light. In the silver staining the gels were first fixed in 50% methanol at 37°C for 30 minutes and then washed twice with deionized water. The gels were treated with 0.1% silver nitrate, 0.056% NaOH and 0.375% NH4OH at 37°C for 15-30 minutes. Color development occurred through incubation with 0.005% citric acid and 0.019% formaldehyde. The gels were washed with deionized water and the color development was stopped with 50% methanol and 5% acetic acid.
According to an alternative silver staining method the gels were first fixed in 10% acetic acid for 20 minutes and then washed three times with deionized water for 2 minutes. The gels were treated with silver nitrate (1 g/1), 1.5 ml 37% formic acid per liter for 30 minutes. The gel was washed with deionized water for 20 seconds. Color development occurred through 2-5 minute incubation with 30 g/1 sodium carbonate, 1.5 ml 37% formic acid per liter and 2 mg/1 Na2S2θ3.5H2O. The color development was stopped by treating the gels with 10% acetic acid for 5 min. All incubations were carried out at room temperature.
Example 2: use of fluorescein isothiocyanate labeled primers followed by analysis with an automatic DNA sequencer
PCR
The PCR was performed for 35 cycles with primers directed against conserved 16S rRNA gene sequences. For this purpose the two primer sets ER1/ER2 and ER3/ER4 were used, the 5 ' -ends of the primers being labeled with fluorescein isothiocyanate (FITC) .
Each cycle consisted of 1 minute at 94°C, 1 minute at 55°C,
10 seconds at 72°C. The PCR reaction mixture (50 μl) consisted of: either 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2, 0.01%
(weight/volume) gelatin, 100 μM of each primer, 1 U Tag- polymerase (Perkin-Elmer Cetus) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP); or 50 mM Tris-HCl (pH 9.0), 50 mM KC1, 7 mM MgCl2, 2 mg/ l bovine serum albumin, 16 mM (NH4)2S04, 100 μM of each primer, 0.1 U
Super-Tag polymerase (HT Biotechnology, Cambridge, UK) and 100 μM of each dNTP (dATP, dCTP, dGTP, dTTP) .
Amplification of target DNA resulted in a DNA fragment of about 218 bp for primer set ER1/ER2 and 255 bp for primer set
ER3/ER4 (small differences depending on bacterial species are possible) .
The primer combinations ER1/ER2 and ER3/ER4 can be combined in one PCR incubation (multiplex PCR) . The analysis accordingly takes place in one lane of the polyacrylamide gel. This increases the number of bands and thereby improves the discrimination between the different species .
Analysis by means of gel electrophoresis After amplification 0.1-1 μl of the PCR mixture was added to 5 μl 95% formamide, 5 mM EDTA and 0.05% dextran blue and heated at 95°C for 5 min. Then the denatured DNA was directly placed on ice and applied to a gel for analysis after 10 minutes.
Analysis was carried out with two types of polyacrylamide gels. In alle cases 10% glycerol was added to improve the resolution. The gel types used are:
-6% hydrolink longranger gel (JT Baker), 0.05% ammonium persulfate and 0.005% TEMED in 54 mM Tris, 54 mM borate, 1.2 mM EDTA (0.6XTBE (pH 8.3)). -0.5 x MDE (Mutation Detection Enhancement) gel (JT Baker), 0.05% ammonium persulfate and 0.005% TEMED in 54 mM Tris, 54 mM borate,
1.2 mM EDTA (0.6xTBE (pH 8.3)).
The use of 0.5xMDE gel gave a better resolution. The gel thickness used was 0.5 mm.
Electrophoresis was carried out at 30°C with 0.6xTBE buffer at 30 W continuous output for 300 minutes for a 20 x 34 cm (1 x b) gel and for 800 minutes for a 30 x 34 cm (1 x b) gel. The electrophoresis was carried out on an ALF DNA sequencer (Pharmacia, Sweden) . Instead of an ALF DNA sequencer, other automatic DNA sequencers can be used as well, such as automatic
DNA sequencers of Applied Biosystems Inc.(CA, USA).
To enable a crood analysis, two internal markers were added to each sample. These markers were used to correct the small local differences in electrophoresis conditions which are present in the gel. The markers consisted of a sequence coming from the gene for toxin B of Clostridium difficile . The size of the markers was chosen such that one marker has a mobility that is greater than that of the products obtained with PCR-SDDM and one marker has a mobility smaller than the PCR-SDDM products. (Note: of course, other DNA sequences meeting the above-mentioned conditions can also be used as markers) .
In total, three markers were used: 150 nucleotides, 203 nucleotides and 257 nucleotides. The markers of 150 and 257 nucleotides were used in multiplex PCR-SDDM with primers ER1/ER2 and ER3/ER4. The markers of 150 and 203 nucleotides were used for
PCR-SDDM with primer combination ER1/ER2 alone.
The markers are obtained with the aid of PCR. For that purpose the following primers were used (nucleotide numbers are derived from the toxin B gene sequence published by L.A. Barroso,
S.Z. Wang, C.J. Phelps, J.L. Johnson, and T.D. Wilkins. Nucleic
Acids Res. 1990, 18: 4004):
91.50 FITC-5'-GTC AGA GAA TAC TGT AGT CG (nucleotide nos. 508-527); 90.11 5'-TCC AAT CCA AAC AAA ATG TA (complementary to nucleotide nos. 691-710);
TOXB321r 5'-CTT TAG CTC TAA TAC TTC TG (complementary to nucleotide nos. 638-657); TOXB428r 5 * -CTA TTT ACA TCT TTC CAT TG (complementary to nucleotide nos. 755-764).
Here 91.50 with 90.11 gives the product of 203 nucleotides, 91.50 with TOXB321r the product of 150 nucleotides and 91.50 with TOXB428r the product of 257 nucleotides. The following PCR conditions were used. A suspension of toxigenic Clostridium diffcile in water was heated at 95°C for 5 min. Ten μl of heated suspension was added to the PCR incubation mixture consisting of 10 mM Tris-HCl (pH 8.3), 50 mM KC1, 1.5 mM MgCl2, 0.01% gelatin, 100 μM of each of the four dNTPs, 50 pmol of each primer (in each case, only two primers were used, one of which was 91.50) and l.OU Tag-polymerase. The PCR was carried out for 35 cycles. Each cycle consisted of 1 min 94°C, 1 min 55°C and 10 sec 72°C.
Used as marker was 0.2 μl of the incubation mixture in 5 μl 95% formamide, 5 mM EDTA and 0.05% dextran blue.
Results Example 1
The method utilizing primer set ER1/ER2 was applied to 114 bacterial strains selected from 40 species and 15 genera. This resulted in 35 different ssDNA band patterns, as summarized in Table 1.
Table 1: PCR-SDDM patterns with primers ER1-ER2 and silver staining
Pattern no. Species (gram-positive) tested number strains
1 Clostridium difficile 11 2 Clostridium bifermentans 1
3 Clostridium butyricum 1 4 Clostridium cadaveris 1
5 Clostridium clostridii forme 1
6 Clostridium histolyticum 1
7 Clostridium innocuum 1 8 Clostridium paraputrificum 1
9 Clostridium perfringens 1
10 Clostridium putrificum 1
11 Clostridium sporogeneε 1
12 Listeria monocytogenes 7 13 Listeria innocua 4
14 Listeria ivanovii 3
15 Listeria grayi 2
16 Staphylococcus aureus 12
17 Staphylococcus epidermidis 4 18 Group A hemolytic Streptococcus 2
19 Acinetojacter calcoaceticus 2
20 Bacteroides fragilis 2
21 Citrobacter freundii 3 Citrobacter amalonaticus 1 22 Escherichia coli 8
Shigella boydii 1
Shigella dysenteriae 1
Shigella flexneri 1 Salmonella enterica subsp. enterica 4 23 Enterbacter aerogenes 3
24 Enterobacter agglomerans 4
25 Enterobacter cloacae 5
26 Enterobacter gergoviae 2
27 Enterobacter sakazakii 1 28 Klebsiella oxytoca 2
29 Klebsiella pneumoniae 3
30 Morganella morganii 2
31 Proteus mirabilis 3 Proteus vulgar is 2 32 Pseudomonas aeruginosa 3 33 Pseudomonas fluorescens 1
34 Pseudomonas malthophilia 3
35 Pseudomonas putida 2
The ssDNA patterns were species-specific, except that the tested Proteus spp. gave the same pattern. The same result was also obtained with Citrobacter freundii and Citrobacter amalonaticus . This was also the case for Escherichia coli / Salmonella enterica / Shigella spp. group. The identical patterns between Escherichia coli and the Shigella spp. were not entirely unexpected because both species are about 99% identical at a genetic level and are considered to be of the same species by some (D.J. Brenner. Introduction to the family Enterobacteriaceae. In: A. Balows, H.G. Truper, M. Dworkin, W. Harder, K.H. Schleifer (eds.) The prokaryotes, 2nd ed. vol. Ill p.2683. Springer-Verlag, N.Y.). The similarity between Escherichia coli and Salmonella enterica was less expected, although the two species are very closely related.
The use of a second primer set (ER3/ER4) largely solved these problems (see Table 2) .
Table 2: PCR-SDDM patterns with primers ER3-ER4 and silver staining
Pattern no. Species tested number of strains
1 Citrobacter amalonaticus 1
2 Citrobacter freundii 2
3 Escherichia coli 5 4 Salmonella en terica susp. enterica 4
5 Shigella flexneri 2 Shigella sonnei 1 Shigella dysenteriae 2
6 Proteus mirabilis 4 7 Proteus vulgaris 2
By using primer set ER3/ER4 it is possible to discriminate Proteus mirabilis from Proteus vulgaris and Citrobacter freundii from Citrobacter amalonaticus . Within the Escherichia coli / Salmonella enterica / Shigella spp. group, a distinction could be made between Escherichia coli , Salmonella enterica and the Shigella . Within the Shigella spp. no distinction could be made.
The primer sets ER1/ER2 and ER3/ER4 can be combined in a multiplex PCR, so that with a single PCR-SDDM analysis the results of the two primer sets can be combined. This does not lead to any loss of discriminative ability.
Although the primer combinations ER5/ER6 and ER7/ER8 give useful results, the best results were obtained with ER1/ER2 and/or ER3/ER4.
Results Example 2
SSDM-PCR with FITC-labeled .1/ER2 primers followed by analysis on an automatic DNA sequencer was applied to 57 bacterial strains selected from 14 species and 7 genera. This resulted in 12 different ssDNA band patterns as summarized in Table 3. Table 3: PCR-SDDM patterns with FITC labeled primers ER1-ER2 and analysis on an automatic sequencer
Pattern no. Species tested number of strains
1 Enterbacter aerogenes 1
2 Enterobacter cloacae 2
3 Escherichia coli 29 Salmonella enterica susp. enterica 2
4 Listeria monocytogenes 2
5 Listeria innocua 2
6 Listeria ivanovii 2
I Listeria grayi 2 8 Klebsiella oxytoca 2
9 Klebsiella pneumoniae 2
10 Proteus mirabilis 2 Proteus vulgaris 1
II Staphylococcus aureus 6 12 Staphylococcus epidermidis 2
The ssDNA band patterns were species-specific, except that the tested Proteus spp. gave the same pattern. This was also the case for Escherichia coli / Salmonella enterica . (These results correspond with the results obtained with the method described in Example 1. )
SSDM-PCR with the FITC-labeled ER1/ER2 and ER3/ER4 primer sets followed by analysis on an automatic DNA sequencer was applied to 41 bacterial strains selected from 10 species and 3 genera. This resulted in 10 different ssDNA patterns as summarized in Table 4. Table 4: Multiplex PCR-SDDM patterns with FITC labeled primers ER1-ER2, ER3-ER4 and analysis on an automatic sequencer.
Pattern no. Species tested number of strains
1 Escherichia coli 2
2 Listeria innocua 3
3 Listeria ivanovii 3 4 Listeria monocytogeneε 3
5 Listeria grayi 5
6 Listeria seeligeri 5
7 Listeria welshimiri 2
8 Staphylococcus aureus 9 9 Staphylococcus epidermidis 7
10 Staphylococcus saprophyticus 2
The ssDNA band patterns with the FITC-labeled primer sets ER1/ER2 and ER3/ER4 are found to be species-specific for the tested bacterial species.
From these results we conclude that it is possible to use the PCR-SDDM method described here for the identification of bacteria. For this, a limited number of primer sets are necessary which result in one or a few ssDNA band patterns for each species. However, the presence of large numbers of bacteria which do not have to be identified may interfere.
Note: At present there is an ongoing discussion about the nomenclature of the Salmonella spp. The WHO (World Health
Organisation) adheres to Salmonella enterica while the American Society for Microbiology adheres to almonella cholerasuis . SEQUENCE LIST
SEQ ID NO:l LENGTH: 20 nucleotides TYPE: nucleotides STRANDEDNESS: single AGGCCCGGGA ACGTATTCAC 20
SEQ ID NO:2
LENGTH: 20 nucleotides TYPE: nucleotides STRANDEDNESS: single GAGGAAGGTG GGGATGACGT 20
SEQ ID NO:3
LENGTH: 17 nucleotides TYPE: nucleotides STRANDEDNESS: single GGCGGACGGG TGAGTAA 17
SEQ ID NO:4
LENGTH: 17 nucleotides TYPE: nucleotides STRANDEDNESS: single
ACTGCTGCCT CCCGTAG 17
SEQ ID NO:5
LENGTH: 20 nucleotides TYPE: nucleotides
STRANDEDNESS: single GCAACGCGAA GAACCTTACC 20 SEQ ID NO : 6
LENGTH: 20 nucleotides TYPE: nucleotides STRANDEDNESS: single AGCCATGCAG CACCTGTCTC 20
SEQ ID NO:7
LENGTH: 20 nucleotides TYPE: nucleotides STRANDEDNESS: single
GGAACTGAAA CATCTAAGTA 20
SEQ TD NO:8
LEI' ': 20 nucleotides TY" lucleotides
ST" -JDNESS: si Tie
CGC ΓGGT TCAcα. ' CGG O

Claims

1. A method for identifying a microorganism present in a sample, comprising: subjecting nucleic acid of the microorganism present in the sample to nucleic acid amplification utilizing one or more sets of universal primers which are based on a gene of the microorganism to be identified which contains both conserved and variable regions, the primers being selected in conserved regions which enclose a variable region; bringing the product of the nucleic acid amplification into single-stranded form; subjecting the amplification product brought into single-stranded form to an electrophoresis which is able to separate single-stranded nucleic acids of equal lengths from each other on the basis of differences in nucleotide sequence; detecting the electrophoresed nucleic acid; and comparing the position of the electrophoresed nucleic acid with those of a set of reference nucleic acids of known microorganisms.
2. A method according to claim 1, wherein said microorganisms consist of bacteria, viruses, fungi, actinomycetes or unicellular parasites.
3. A- method according to claim 1, wherein said microorganisms consist of bacteria.
4. A method according to claim 3, wherein said sets of universal primers are based on the 16S rRNA gene or the 23S rRNA gene of bacteria.
5. A method according to claim 4, wherein a set of primers is used based on the regions 1173-1192 and 1370-1389 of the 16S rRNA gene, such as the primer set ER1: AGG CCC GGG AAC GTA TTC AC ER2: GAG GAA GGT GGG GAT GAC GT and/or a set of primers is used based on the regions 103-119 and 341-357 of the 16S rRNA gene, such as the primer set
ER3: GGC GGA CGG GTG AGT AA
ER4: ACT GCT GCC TCC CGT AG and/or a set of primers is used based on the regions 966-985 and 1041-1060 of the 16S rRNA gene, such as the primer set
ER5: GCA ACG CGA AGA ACC TTA CC
ER6: AGC CAT GCA GCA CCT GTC TC and/or a set of primers is used based on the regions 188-207 and 444-463 of the 23S rRNA gene, such as the primer set
ER7: GGA ACT GAA ACA TCT AAG TA
ER8: CGG TAC TGG TTC ACT ATC GG.
6. A method according to claim 1, wherein at least two sets of primers are used in the nucleic acid amplification.
7. A method according to claim 6, wherein said at least two sets of primers are used simultaneously in a multiplex amplification.
8. A method according to claim 6 or 7, wherein the primer sets ER1/ER2 and ER3/ER4 are used.
9. A method according to claim 6, wherein a 'nested' nucleic acid amplification is carried out whereby a first amplification with a first set of primers is followed by a second amplification with a second set of primers, the primers of the second set being based on regions located between those of the first set of primers.
10. A method according to claim 1, wherein the nucleic acid amplification consists of a polymerase chain reaction (PCR) utilizing a DNA polymerase.
11. A method according to claim 10, wherein use is made of a thermostable DNA polymerase.
12. A method according to claim 11, wherein Tag-polymerase, Vent-polymerase, Tth-polymerase, or SuperTag-polymerase is uε 1.
13. A method according to claim 10, wherein said DNA polymer .. is subjected to a pretreatment whereby contaminating DNA and/or RNA is removed.
14. A method according to claim 10, wherein the target nucleic acid consists of DNA selected from genomic DNA of the microorganism and cDNA synthesized by reverse transcription of RNA of the microorganism.
15. A method according to claim 1, wherein the nucleic acid amplification is carried out according to a transcription-based amplification system (TAS) .
16. A method according to claim 15, wherein the nucleic acid amplification is carried out according to a self-sustained sequence replication (3SR) reaction, a nucleic acid system based amplification (NASBA) or a template mediated amplification (TMA) .
17. A method according to claim 15, wherein the target nucleic acid consists of RNA or DNA of the microorganism.
18. A method according to claim 1, wherein, for the purpose of detecting the amplified and electrophoresed nucleic acid, labeled primers or labeled nucleotides are used during the nucleic acid amplification.
19. A method according to claim 18, wherein radioactively labeled primers or nucleotides are used during the nucleic acid amplification.
20. A method according to claim 18, wherein during the nucleic acid amplification, primers are used which are labeled with a fluorochrome, a chemiluminescent substance, biotin or digoxigenin.
21. A- method according to claim 1, wherein the amplified and electrophoresed nucleic acid is detected by staining.
22. A method according to claim 21, wherein the detection of the amplified and electrophoresed nucleic acid is carried out by silver staining, ethidium bromide staining or Stains-all staining.
23. A method according to claim 1, wherein for said electrophoresis of single-stranded nucleic acid, use is made of a polyacrylamide gel electrophoresis under non-denaturing conditions.
24. A method according to claim 1, wherein the product of the amplification consists of double-stranded DNA, which is brought into single-stranded form by heating before it is subjected to said electrophoresis.
25. A method according to claim 1, wherein the product of the amplification consists of single-stranded RNA, which is subsequently subjected to said electrophoresis.
26. A method according to claim 1, wherein the nucleic acid of the microorganism present in the sample is isolated from the sample before it is subjected to nucleic acid amplification.
27. A method according to claim 1, wherein the sample consists of a clinical sample, such as urine, feces, sputum or blood, or a food.
28. An aid suitable for use in the method according to claim 1, comprising a set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
29. A set of aids suitable for use in the method according to claim 1, comprising: a nucleic acid amplification kit with one or more sets of universal primers based on a gene of the microorganism to be identified which comprises both conserved and variable regions, the primers being selected in conserved regions which enclose a variable region; an electrophoresis kit for an electrophoresis which is able to separate single-stranded nucleic acids of equal lengths from each other on the basis of differences in nucleotide sequence; means for detecting labeled or unlabeled electrophoresed nucleic acid; and a set of electrophoresis patterns of nucleic acids of microorganisms serving as reference.
PCT/NL1994/000283 1993-11-11 1994-11-11 A method for identifying microorganisms, and aids useful thereof WO1995013396A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9301957A NL9301957A (en) 1993-11-11 1993-11-11 Method for identifying microorganisms, and useful tools.
NL9301957 1993-11-11

Publications (2)

Publication Number Publication Date
WO1995013396A2 true WO1995013396A2 (en) 1995-05-18
WO1995013396A3 WO1995013396A3 (en) 1995-06-08

Family

ID=19863128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1994/000283 WO1995013396A2 (en) 1993-11-11 1994-11-11 A method for identifying microorganisms, and aids useful thereof

Country Status (2)

Country Link
NL (1) NL9301957A (en)
WO (1) WO1995013396A2 (en)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2300481A (en) * 1994-10-14 1996-11-06 Univ Wales Monitoring endospore-forming bacteria by amplification of DNA of conserved regions
DE19716456A1 (en) * 1997-04-21 1998-10-22 Schmitt Heinz Josef Prof Dr Identification of microorganisms, especially respiratory tract pathogens
US5876924A (en) * 1994-06-22 1999-03-02 Mount Sinai School Of Medicine Nucleic acid amplification method hybridization signal amplification method (HSAM)
WO1999013104A1 (en) * 1997-09-08 1999-03-18 The Institute Of Ophthalmology Diagnosis of ocular pathogens
WO1999035285A2 (en) * 1998-01-08 1999-07-15 Merck Sharp & Dohme De Espana, S.A.E. Hybridization probes which differentiate between the actinomadura madurae group of bacteria and maduromycetes
US5942391A (en) * 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
WO2000065088A2 (en) * 1999-04-26 2000-11-02 Amersham Pharmacia Biotech Ab Primers for identifying typing or classifying nucleic acids
WO2001023608A2 (en) * 1999-09-27 2001-04-05 Merck Sharp & Dohme De Espana, S.A.E. Hybridization probes which specifically detect strains of the genera microbispora, microtetraspora, nonomuria and planobispora
WO2001023606A3 (en) * 1999-09-24 2002-09-06 Biotecon Diagnostics Gmbh Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria
US6593086B2 (en) 1996-05-20 2003-07-15 Mount Sinai School Of Medicine Of New York University Nucleic acid amplification methods
USRE38442E1 (en) * 1994-06-22 2004-02-24 Mount Sinai School Of Medicine Nucleic acid amplification method hybridization signal amplification method (HSAM)
US7205111B2 (en) * 2003-07-24 2007-04-17 Marshfield Clinic Rapid identification of bacteria from positive blood cultures
US7217510B2 (en) * 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
EP1790735A1 (en) * 1999-12-23 2007-05-30 Roche Diagnostics GmbH Oligonucleotides for rapid determination of microbial DNS/RNS
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US7741036B2 (en) 2001-03-02 2010-06-22 Ibis Biosciences, Inc. Method for rapid detection and identification of bioagents
WO2011048227A1 (en) * 2009-10-22 2011-04-28 Biotools Biotechnological & Medical Laboratories, S.A. Composition, method and kit for detecting bacteria by means of sequencing
US7956175B2 (en) 2003-09-11 2011-06-07 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
EP2386615A1 (en) * 2010-04-26 2011-11-16 Nitto Denko Corporation Pressure-sensitive adhesive sheet
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8088582B2 (en) 2006-04-06 2012-01-03 Ibis Biosciences, Inc. Compositions for the use in identification of fungi
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US8173957B2 (en) 2004-05-24 2012-05-08 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
US8187814B2 (en) 2004-02-18 2012-05-29 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8214154B2 (en) 2001-03-02 2012-07-03 Ibis Biosciences, Inc. Systems for rapid identification of pathogens in humans and animals
US8268565B2 (en) 2001-03-02 2012-09-18 Ibis Biosciences, Inc. Methods for identifying bioagents
US8407010B2 (en) 2004-05-25 2013-03-26 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8551738B2 (en) 2005-07-21 2013-10-08 Ibis Biosciences, Inc. Systems and methods for rapid identification of nucleic acid variants
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US8563250B2 (en) 2001-03-02 2013-10-22 Ibis Biosciences, Inc. Methods for identifying bioagents
US8822156B2 (en) 2002-12-06 2014-09-02 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
US9080209B2 (en) 2009-08-06 2015-07-14 Ibis Biosciences, Inc. Non-mass determined base compositions for nucleic acid detection
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
AU2013231102B2 (en) * 2001-03-02 2016-04-28 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US9393564B2 (en) 2009-03-30 2016-07-19 Ibis Biosciences, Inc. Bioagent detection systems, devices, and methods
US9416409B2 (en) 2009-07-31 2016-08-16 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US9719083B2 (en) 2009-03-08 2017-08-01 Ibis Biosciences, Inc. Bioagent detection methods
US9758840B2 (en) 2010-03-14 2017-09-12 Ibis Biosciences, Inc. Parasite detection via endosymbiont detection
US9873906B2 (en) 2004-07-14 2018-01-23 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
CN114207154A (en) * 2019-03-15 2022-03-18 波利斯科普实验室 Selective enrichment broth for detecting one or more pathogens

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001560A1 (en) * 1988-07-29 1990-02-22 David John Evans Bacterial dna probe
WO1990015157A1 (en) * 1989-05-31 1990-12-13 Gene-Trak Systems Universal eubacteria nucleic acid probes and methods
EP0479117A1 (en) * 1990-10-05 1992-04-08 F. Hoffmann-La Roche Ag Methods and reagents for identifying bacteria
WO1993005179A1 (en) * 1991-08-29 1993-03-18 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES:National Institutes of Health A method for discriminating and identifying alleles in complex loci

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001560A1 (en) * 1988-07-29 1990-02-22 David John Evans Bacterial dna probe
WO1990015157A1 (en) * 1989-05-31 1990-12-13 Gene-Trak Systems Universal eubacteria nucleic acid probes and methods
EP0479117A1 (en) * 1990-10-05 1992-04-08 F. Hoffmann-La Roche Ag Methods and reagents for identifying bacteria
WO1993005179A1 (en) * 1991-08-29 1993-03-18 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES:National Institutes of Health A method for discriminating and identifying alleles in complex loci

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
G. SARKAR ET AL.: "Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP", NUCL. ACIDS RES., vol. 20 , page 871, IRL PRESS, OXFORD, ENGLAND; cited in the application *
G. VAN CAMP ET AL.: "Amplification and sequencing of variable regions in bacterial 23S ribosomal RNA genes with conserved primer sequences", CURRENT MICROBIOL., vol. 27, no. 3 , pages 147-151, SPRINGER INTERNATIONAL, NEW YORK, US cited in the application *
J. BROSIUS ET AL.: "Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli", PROC. NATL.ACAD SCI., vol. 75, no. 10 , pages 4801-4805, NATL. ACAD SCI.,WASHINGTON,DC,US; *
K. CHEN ET AL.: "Broad range DNA probes for detecting and amplifying eubacterial nucleic acids", FEMS MICROBIOLGY LETTERS, vol. 57 , page 19, ELSEVIER, AMSTERDAM, NL; cited in the application *
M.N. WIDJOJOATMODJO ET AL.: "Rapid identification of bacteria by single-strand conformation polymorphism", J. CLIN. MICROBIOL., vol. 32, no. 12 , pages 3002-3007, ASM, WASHINGTON,DC,US *

Cited By (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569647B1 (en) 1994-06-22 2003-05-27 Mount Sinai School Of Medicine Of New York University Nucleic acid amplification method: ramification-extension amplification method (RAM)
US5876924A (en) * 1994-06-22 1999-03-02 Mount Sinai School Of Medicine Nucleic acid amplification method hybridization signal amplification method (HSAM)
US8632999B1 (en) 1994-06-22 2014-01-21 David Y. Zhang Nucleic acid amplification methods
US5942391A (en) * 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
US6855523B2 (en) 1994-06-22 2005-02-15 Mount Sinai School Of Medicine Of New York University Nucleic acid amplification method: ramification-extension amplification method (RAM)
USRE38442E1 (en) * 1994-06-22 2004-02-24 Mount Sinai School Of Medicine Nucleic acid amplification method hybridization signal amplification method (HSAM)
GB2300481B (en) * 1994-10-14 1998-12-02 Univ Wales Monitoring endospore-forming bacteria involving the amplification of DNA of conserved regions thereof
GB2300481A (en) * 1994-10-14 1996-11-06 Univ Wales Monitoring endospore-forming bacteria by amplification of DNA of conserved regions
US6593086B2 (en) 1996-05-20 2003-07-15 Mount Sinai School Of Medicine Of New York University Nucleic acid amplification methods
DE19716456A1 (en) * 1997-04-21 1998-10-22 Schmitt Heinz Josef Prof Dr Identification of microorganisms, especially respiratory tract pathogens
DE19716456C2 (en) * 1997-04-21 2002-05-08 Schmitt Heinz Josef Use of a combination of primers for the detection of infectious agents
WO1999013104A1 (en) * 1997-09-08 1999-03-18 The Institute Of Ophthalmology Diagnosis of ocular pathogens
WO1999035285A2 (en) * 1998-01-08 1999-07-15 Merck Sharp & Dohme De Espana, S.A.E. Hybridization probes which differentiate between the actinomadura madurae group of bacteria and maduromycetes
WO1999035285A3 (en) * 1998-01-08 1999-10-14 Merck Sharp & Dohme De Espana Hybridization probes which differentiate between the actinomadura madurae group of bacteria and maduromycetes
WO2000065088A3 (en) * 1999-04-26 2001-08-09 Amersham Pharm Biotech Ab Primers for identifying typing or classifying nucleic acids
WO2000065088A2 (en) * 1999-04-26 2000-11-02 Amersham Pharmacia Biotech Ab Primers for identifying typing or classifying nucleic acids
WO2001023606A3 (en) * 1999-09-24 2002-09-06 Biotecon Diagnostics Gmbh Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria
US7202027B1 (en) 1999-09-24 2007-04-10 Biotecon Diagnostics Gmbh Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria
WO2001023608A3 (en) * 1999-09-27 2003-04-17 Merck Sharp & Dohme De Espana Hybridization probes which specifically detect strains of the genera microbispora, microtetraspora, nonomuria and planobispora
WO2001023608A2 (en) * 1999-09-27 2001-04-05 Merck Sharp & Dohme De Espana, S.A.E. Hybridization probes which specifically detect strains of the genera microbispora, microtetraspora, nonomuria and planobispora
US7291724B2 (en) 1999-12-23 2007-11-06 Roche Diagnostics Corporation Oligonucleotides for rapidly identifying microbial DNA or RNA
EP1790735A1 (en) * 1999-12-23 2007-05-30 Roche Diagnostics GmbH Oligonucleotides for rapid determination of microbial DNS/RNS
US8815513B2 (en) 2001-03-02 2014-08-26 Ibis Biosciences, Inc. Method for rapid detection and identification of bioagents in epidemiological and forensic investigations
US8265878B2 (en) 2001-03-02 2012-09-11 Ibis Bioscience, Inc. Method for rapid detection and identification of bioagents
US9752184B2 (en) 2001-03-02 2017-09-05 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7741036B2 (en) 2001-03-02 2010-06-22 Ibis Biosciences, Inc. Method for rapid detection and identification of bioagents
US8214154B2 (en) 2001-03-02 2012-07-03 Ibis Biosciences, Inc. Systems for rapid identification of pathogens in humans and animals
US9416424B2 (en) 2001-03-02 2016-08-16 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US8268565B2 (en) 2001-03-02 2012-09-18 Ibis Biosciences, Inc. Methods for identifying bioagents
AU2013231102B2 (en) * 2001-03-02 2016-04-28 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US8017358B2 (en) 2001-03-02 2011-09-13 Ibis Biosciences, Inc. Method for rapid detection and identification of bioagents
US8563250B2 (en) 2001-03-02 2013-10-22 Ibis Biosciences, Inc. Methods for identifying bioagents
US8802372B2 (en) 2001-03-02 2014-08-12 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US8921047B2 (en) 2001-06-26 2014-12-30 Ibis Biosciences, Inc. Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
US7217510B2 (en) * 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8380442B2 (en) 2001-06-26 2013-02-19 Ibis Bioscience, Inc. Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
US8298760B2 (en) * 2001-06-26 2012-10-30 Ibis Bioscience, Inc. Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
US8822156B2 (en) 2002-12-06 2014-09-02 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US9725771B2 (en) 2002-12-06 2017-08-08 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8476415B2 (en) 2003-05-13 2013-07-02 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7205111B2 (en) * 2003-07-24 2007-04-17 Marshfield Clinic Rapid identification of bacteria from positive blood cultures
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7956175B2 (en) 2003-09-11 2011-06-07 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8394945B2 (en) 2003-09-11 2013-03-12 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8013142B2 (en) 2003-09-11 2011-09-06 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US8187814B2 (en) 2004-02-18 2012-05-29 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US9447462B2 (en) 2004-02-18 2016-09-20 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8987660B2 (en) 2004-05-24 2015-03-24 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US8173957B2 (en) 2004-05-24 2012-05-08 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US9449802B2 (en) 2004-05-24 2016-09-20 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US8407010B2 (en) 2004-05-25 2013-03-26 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA
US9873906B2 (en) 2004-07-14 2018-01-23 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8551738B2 (en) 2005-07-21 2013-10-08 Ibis Biosciences, Inc. Systems and methods for rapid identification of nucleic acid variants
US8088582B2 (en) 2006-04-06 2012-01-03 Ibis Biosciences, Inc. Compositions for the use in identification of fungi
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US9023655B2 (en) 2008-09-16 2015-05-05 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US9027730B2 (en) 2008-09-16 2015-05-12 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8252599B2 (en) 2008-09-16 2012-08-28 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8609430B2 (en) 2008-09-16 2013-12-17 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US9165740B2 (en) 2009-02-12 2015-10-20 Ibis Biosciences, Inc. Ionization probe assemblies
US8796617B2 (en) 2009-02-12 2014-08-05 Ibis Biosciences, Inc. Ionization probe assemblies
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US9719083B2 (en) 2009-03-08 2017-08-01 Ibis Biosciences, Inc. Bioagent detection methods
US9393564B2 (en) 2009-03-30 2016-07-19 Ibis Biosciences, Inc. Bioagent detection systems, devices, and methods
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
US9416409B2 (en) 2009-07-31 2016-08-16 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
US10119164B2 (en) 2009-07-31 2018-11-06 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
US9080209B2 (en) 2009-08-06 2015-07-14 Ibis Biosciences, Inc. Non-mass determined base compositions for nucleic acid detection
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
WO2011048227A1 (en) * 2009-10-22 2011-04-28 Biotools Biotechnological & Medical Laboratories, S.A. Composition, method and kit for detecting bacteria by means of sequencing
US9758840B2 (en) 2010-03-14 2017-09-12 Ibis Biosciences, Inc. Parasite detection via endosymbiont detection
EP2386615A1 (en) * 2010-04-26 2011-11-16 Nitto Denko Corporation Pressure-sensitive adhesive sheet
CN114207154A (en) * 2019-03-15 2022-03-18 波利斯科普实验室 Selective enrichment broth for detecting one or more pathogens
JP2022527680A (en) * 2019-03-15 2022-06-02 ポリスコープ・ラボ Selective enrichment broth to detect one or more pathogens
EP3938532A4 (en) * 2019-03-15 2022-11-30 Polyskope Labs Selective enrichment broth for detection of one or more pathogens

Also Published As

Publication number Publication date
NL9301957A (en) 1995-06-01
WO1995013396A3 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
WO1995013396A2 (en) A method for identifying microorganisms, and aids useful thereof
JP2709256B2 (en) Mycobacterial probe
EP0630971A2 (en) Method, reagents and kits for detection of neisseria gonorrhoea
JP2006505275A (en) One-step real-time RT-PCR kit for universal detection of microorganisms in industrial products
KR19990008049A (en) Universal targets for species identification
US5681705A (en) Amplification and detection of mycobacterium avium complex species
US5494796A (en) Detection and identification of mycobacteria
US5500341A (en) Species-specific detection of Mycobacterium kansasii
EP1019532B1 (en) Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae
JPH09248193A (en) Amplification and detection of mycobacterium avium complex species
US5518884A (en) Nucleic acid sequences specific for mycbacterium kansasii
US5985569A (en) Primers for amplification of a genus specific sequence of the mycobacterium 16S rRNA gene
JP4744053B2 (en) Nucleic acid amplification and detection of Mycobacterium species
US7326533B2 (en) Detection rpoB sequences of Mycobacterium tuberculosis
WO1997032036A9 (en) Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae
US5723296A (en) Amplification and detection of mycobacterial DNA K nucleic acids
EP1252331B1 (en) Methods and compositions for detection of mycobacterium avium complex species
JP4441259B2 (en) Method for detecting Gram-positive bacteria
JP4455881B2 (en) Detection of rpoB sequence of Mycobacterium tuberculosis
CA2086871A1 (en) Method and reagents for determining the presence of giardia lamblia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA